AstraZeneca PLC (AZN.L)
| Previous close | 10,950.00 |
| Open | 10,904.00 |
| Bid | 10,992.00 x 0 |
| Ask | 10,994.00 x 0 |
| Day's range | 10,904.00 - 11,079.00 |
| 52-week range | 9,499.21 - 12,828.45 |
| Volume | |
| Avg. volume | 2,032,357 |
| Market cap | 171.712B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 34.57 |
| EPS (TTM) | 3.18 |
| Earnings date | 09 Nov 2023 |
| Forward dividend & yield | 2.35 (2.21%) |
| Ex-dividend date | 10 Aug 2023 |
| 1y target est | 128.27 |
ReutersAstraZeneca refused to pay full bonus to US remote worker, lawsuit claims
AstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who claims the drugmaker refused to pay her nearly $130,000 in promised bonuses and stock options because she worked from home full-time. Elmarie Bodes, who was AstraZeneca's senior director of business transformation until January, said in the lawsuit filed in South Carolina state court on Tuesday that she was owed a $124,000 performance bonus and $65,000 in stock options. Instead, AstraZeneca earlier this year cut her payout in half and refused to grant any stock options because she did not come into the office at least three days per week, according to the lawsuit.
ZacksAstrazeneca (AZN) Gains As Market Dips: What You Should Know
Astrazeneca (AZN) closed at $68.27 in the latest trading session, marking a +0.72% move from the prior day.
ZacksInvestors Heavily Search AstraZeneca PLC (AZN): Here is What You Need to Know
Zacks.com users have recently been watching Astrazeneca (AZN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
